A role for PI3K-Akt signaling in pulmonary metastatic nodule formation of the osteosarcoma cell line, LM8

Oncology Reports

Volumn 14, Issue 4, 2005, Pages 847-852

  Fukaya, Yasushi ^a   Ishiguro, Naoki ^a   Senga, Takeshi ^a   Ichigotani, Yasukatsu ^a   Sohara, Yasuyoshi ^a   Tsutsui, Motomu ^a   Shioura, Tomone ^a   Iwamoto, Takashi ^a   Hamaguchi, Michinari ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Akt; Matrix metalloproteinase; Osteosarcoma; PI3 kinase; Pulmonary metastasis

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; CYTOSKELETON PROTEIN; ENZYME INHIBITOR; EZRIN; GELATINASE A; GELATINASE B; MORPHOLINE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN; PROTEIN KINASE B;

ARTICLE; CANCER INVASION; CELL MOTION; HUMAN; IMMUNOBLOTTING; LUNG TUMOR; METABOLISM; METASTASIS; OSTEOSARCOMA; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE, TUMOR; CELL MOVEMENT; CHROMONES; CYTOSKELETAL PROTEINS; ENZYME INHIBITORS; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MORPHOLINES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OSTEOSARCOMA; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

EID: 33644823860     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.4.847     Document Type: Article

References (29)

1. Schajowicz F: Histological typing of bone tumors. 2nd edition. WHO. Splinger-Verlag, Berlin, pp10-13, 1993.
2. Wunder JS, Bull SB, Aneliunas V, Lee PD, Davis AM, Beauchamp CPW, Conrad EU, Grimer RJ, Healey JH, Rock MJ, Bell RS and Andrulis IL: MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study. J Clin Oncol 18: 2685-2694, 2000. (Pubitemid 30463550)
3. Whelan JS: Osteosarcoma. Eur J Cancer 33: 1611-1618, 1997.
4. Dunn TB and Andervont HB: Histology of some neoplasm and non-neoplastic lesions found in wild mice maintained under laboratory conditions. J nat Cancer 31: 873-901, 1963.
5. Ueda T, Aoki Y, Yoshikawa H, Kato T, Hamada H and Ono K: Establishment of highly pulmonary metastatic cell line of murine osteosarcoma. Jpn J Orthop Res (in Japanese) 13: 705-708, 1986.
6. Poste G and Fidler IJ: The pathogenesis of cancer metastasis. Nature 283: 139-146, 1980. (Pubitemid 10171124)
7. Asai T, Uchida T, Itoh K, Yoshikawa K, Aoki Y, Mori S and Yoshikawa H: Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer 76: 418-422, 1998. (Pubitemid 28282943)
8. Birkedal-Hansen H, Moore WG, Borden MK, Windsor LJ, Birkedal-Hansen B, De Carlo A and Engler JA: Matrix matalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250, 1993.
9. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E and Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994. (Pubitemid 24216953)
10. Ueno H, Nakamura H, Inoue M, Noguchi M, Sato H, Seiki M and Okada Y: Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 57: 2055-2060, 1997. (Pubitemid 27209741)
11. Okada N, Ishida H, Murata N, Hashimoto D, Seyama Y and Kubota S: Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer. Biochem Biophys Res Commun 288: 212-216, 2001. (Pubitemid 32999748)
12. Zhang Y, Thant AA, Hiraiwa Y, Naito Y, Sein TT, Sohara Y, Matsuda S and Hamaguchi M: A role for focal adhesion kinase in hyaluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QC90. Biochem Biophys Res Commun 290: 1123-1127, 2002. (Pubitemid 34687480)
13. Thant AA, Nawa A, Kikkawa F, Ichigotani Y, Zhang Y, Sein TT, Amin AR and Hamaguchi M: Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-AKT pathways in ovarian cancer cells. Clin Exp Metastasis 18: 423-428, 2000. (Pubitemid 32588623)
14. Staal SP: Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.Proc Natl Acad Sci USA 84: 5034-5037, 1987.
15. Franke TF, Kaplan DR, Cantley LC and Toker A: Direct regulation of the Akt proto-oncogene product by phosphatidyl-inositol- 3,4-bisphosphate. Science 275: 665-668, 1997. (Pubitemid 27061333)
16. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241, 1997. (Pubitemid 27456390)
17. Cardone MH, Roy N, Stennicke HR, Salvasen GS, Franke TF, Stanbridege E, Frisch S and Reed JC: Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321, 1998. (Pubitemid 28524494)
18. Bond M, Fabunmi RP, Baker AH and Newby AC: Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappaB. FEBS Lett 435: 29-34, 1998. (Pubitemid 28432009)
19. Amin AR, Senga T, Oo ML, Thant AA and Hamaguchi M: Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signaling pathways, Akt and Erk. Genes Cells 8: 515-523, 2003. (Pubitemid 36748455)
20. Khanna C, Wan X, Bose S, Cassaday R, Olomu O and Heiman LJ: The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med 10: 182-186, 2004. (Pubitemid 38524889)
21. Sheila MNP, Selina RS and Jennifer MG: Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells. J Cell Biochem 90: 964-975, 2003.
22. Thant AA, Serbulea M, Kikkawa F, Liu E, Tomoda Y and Hamaguchi M: c-Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells. FEBS Lett 406: 28-30, 1997. (Pubitemid 27156951)
23. Sohara Y, Ishiguro N, Machida K, Kurata H, Thant AA, Senga T, Matsuda S, Kimata K, Iwata H and Hamaguchi M: Hyaluronan activates cell motility of v-Src-transformed cells via Ras-mitogen-activated protein kinase and phosphoinositide3-kinase-Akt in a tumor-specific manner. Mol Biol Cell 12: 1859-1868, 2001. (Pubitemid 33049736)
24. Zhang Y, Thant AA, Machida K, Ichigotani Y, Naito Y, Hiraiwa Y, Senga T, Sohara Y, Matsuda S and Hamaguchi M: Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res 62: 3962-3965, 2002. (Pubitemid 34791060)
25. Hamaguchi M, Matsuyoshi N, Ohnishi Y, Gotoh B, Takeichi M and Nagai Y: p60v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system EMBO J 12: 307-314, 1993. (Pubitemid 23042409)
26. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868, 1999. (Pubitemid 29165088)
27. Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA and McCubrey JA: Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17: 590-603, 2003. (Pubitemid 36395654)
28. Grille SJ, Bellacosa A, Upson J, Klein-Szanto Aj, van Roy F, Lee-Kwon W, Donowitz M, Tsichlis PN and Larue L: The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63: 2172-2178, 2003. (Pubitemid 36538623)
29. Keely PJ, Westwick JK, Whitehead IP, Der CJ and Parise LV: Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI3K. Nature 390: 632-636, 1997. (Pubitemid 28016201)